Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer

Cambridge, Business

Synlogic Presents at Global PKU Patient Meeting

Cambridge, Business

PAQ Therapeutics Announces Collaboration with Insilico Medicine to Develop Novel Therapies through Autophagy-Dependent Degradation

Cambridge, Business

MIT J-WEL welcomes the American School of Marrakesh as newest pK-12 member

Cambridge

Convergent Therapeutics Appoints Alexander Brown as Chief Operating Officer

Cambridge, Business

New 30 Patient Study Of AOBiome's New Shelf-Stable Formulation Of Its Ammonia Oxidizing Bacteria (AOB) Shows Reduction Of Itch Levels In Both Pediatric And Adult Subjects Who Suffer From Eczema.

Cambridge, Business

Paragonix Technologies Announces the Launch of the New OPTION On-Demand Preservation Services Network

Cambridge, Business

Keeeb unveils Keeeb for Office - raising the bar on employee search experience

Cambridge, Business

HubEngage and Tango Card Launch Strategic Partnership to Bring Gift Card Incentives to Companies Seeking to Enhance Employee Engagement and Rewards

Cambridge, Business

Mayo Clinic and nference Study Links Pre-Existing Conditions to Short- and Long-Term COVID-19 Complications

Cambridge, Business

David P. White, M.D. Appointed Senior Vice President of Medical Affairs at Apnimed

Cambridge, Business

Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC

Cambridge, Business

Free Future Legal Eagles Flight School National Pre-Law Summit for Black Youth and Parents Launches This Week

Cambridge

Ribon Therapeutics Announces Publication in Cancer Cell of Pre-Clinical and Mechanism of Action Data for RBN-2397

Cambridge, Business

Synlogic Publishes Papers in Nature Journals Demonstrating Proof-of-Mechanism and Potential of Synthetic Biotic Platform for the Treatment of Phenylketonuria (PKU)

Cambridge, Business

Sesen Bio Announces New Appointments to its Board of Directors

Cambridge, Business

bluebird bio Receives EC Approval for SKYSONA™ (elivaldogene autotemcel, Lenti-D™) Gene Therapy for Patients Less Than 18 Years of Age With Early Cerebral Adrenoleukodystrophy (CALD) Without Matched Sibling Donor

Cambridge, Business

Superpedestrian Unlocks E-Scooter Safety Breakthrough With Acquisition of Navmatic USA - English USA - English USA - English

Cambridge, Business

Quantori Expands Executive Team, Appoints Sean Murphy as Vice President, Client Services

Cambridge, Business

Foundation Medicine Expands Indication for FoundationOne®Liquid CDx to be Used as a Companion Diagnostic for TABRECTA® (capmatinib)

Cambridge, Business

Synlogic Announces Initiation of Phase 1 Study of SYNB1934, a Next-Generation Strain for the Treatment of Phenylketonuria (PKU)

Cambridge, Business